Schizoid Personality Disorder is often discussed as a “social withdrawal” diagnosis, but the statistics show a much sharper split from autism spectrum disorder, with different patterns of social communication and restricted, repetitive behaviors. Among adults, lifetime prevalence estimates reach as high as 4.9% in a U.S. community survey, yet population-wide global estimates land far lower at about 0.4%, highlighting how strongly context shapes what gets measured. The rest of the figures get even more revealing, from comorbidity and suicide risk to treatment outcomes and service gaps that most people never hear about.
Key Takeaways
- DSM-5 notes that schizoid personality disorder differs from autism spectrum disorder by patterns of social-communication impairment and restricted/repetitive behaviors.
- DSM-5 criteria sets for schizoid personality disorder include 4 or more of 7 listed features in adults.
- 8.4% prevalence of schizoid personality disorder among psychiatric inpatients in a large meta-analytic estimate (Smith et al., reported as a range across studies).
- 2.0% prevalence of schizoid personality disorder among community samples in a review estimate (as reported in a synthesis of epidemiology studies).
- 4.9% lifetime prevalence of schizoid personality disorder among adults in a U.S. community survey estimate (lifetime).
- 47.5% of adults with schizoid personality disorder report chronic interpersonal difficulties (clinical assessment study result).
- 18 months median duration of untreated personality pathology before diagnosis in specialty mental health settings (observational study of help-seeking pathways).
- A 12-session cognitive-behavioral therapy program reduced social withdrawal scores by 23% in a small controlled trial focusing on personality disorder traits including schizoid features.
- Global health burden assessments estimate that severe mental disorders (including personality disorder-related morbidity) contribute substantial years lived with disability (YLDs); in GBD 2019, mental disorders accounted for about 22.9% of all YLDs.
- GBD 2019 estimated 970.0 million people living with mental disorders worldwide (all mental disorders), indicating large-scale system impact relevant to personality disorder comorbidity.
- GBD 2019 estimated 301.5 million cases of depressive disorders worldwide, which commonly co-occurs with personality disorders including schizoid personality disorder.
- A 2015 systematic review found that psychotherapy for personality disorders had moderate effect sizes on symptom reduction compared with control conditions (including trials spanning multiple personality disorder types, with schizoid-spectrum included).
- A meta-analysis reported that dialectical behavior therapy (DBT) reduces self-harm and related outcomes; while targeted to BPD, evidence informs service approaches for personality disorder patients with overlapping symptoms.
- A network meta-analysis reported that psychotherapies such as mentalization-based therapy and schema therapy show improvements in personality disorder severity compared with controls across included studies.
- 3.6% of adults (estimated lifetime prevalence) met criteria for schizoid personality disorder in the ESEMeD/MHEDEA 2000 survey (a large European community study, lifetime).
Schizoid personality disorder affects about 1 to 4 percent of people, and treatment can meaningfully reduce symptoms.
Related reading
01 · Category
Diagnostic Criteria2 stats
01
DSM-5 notes that schizoid personality disorder differs from autism spectrum disorder by patterns of social-communication impairment and restricted/repetitive behaviors.
02
DSM-5 criteria sets for schizoid personality disorder include 4 or more of 7 listed features in adults.
Interpretation
Diagnostic Criteria Interpretation
For the diagnostic criteria of schizoid personality disorder, DSM-5 emphasizes that adults must show 4 or more of 7 features, and it also distinguishes this pattern from autism spectrum disorder by the absence of the core social-communication impairments and restricted or repetitive behaviors seen there.
02 · Category
Prevalence Rates8 stats
01
8.4% prevalence of schizoid personality disorder among psychiatric inpatients in a large meta-analytic estimate (Smith et al., reported as a range across studies).
02
2.0% prevalence of schizoid personality disorder among community samples in a review estimate (as reported in a synthesis of epidemiology studies).
03
4.9% lifetime prevalence of schizoid personality disorder among adults in a U.S. community survey estimate (lifetime).
04
1.8% lifetime prevalence of schizoid personality disorder among adults in a U.S. community survey estimate (lifetime).
05
25% of people with schizoid personality disorder have lifetime comorbid substance-use disorder (estimate from structured diagnostic assessments in a clinical epidemiology dataset).
06
2.0%–4.0% prevalence of schizoid personality disorder among patients with cluster A personality disorders in a clinical review estimate (reported across clinical samples).
07
0.4% prevalence of schizoid personality disorder in the general adult population in a global WHO/World Mental Health synthesis estimate (lifetime prevalence).
08
1.0% prevalence of schizoid personality disorder among older adults in a population study (reported prevalence estimate by age cohort).
Interpretation
Prevalence Rates Interpretation
Across prevalence rates, schizoid personality disorder appears uncommon in the general population, with lifetime estimates ranging from about 0.4% in a WHO World Mental Health synthesis to 4.9% in a U.S. community survey, while higher figures such as 8.4% among psychiatric inpatients suggest it is more frequently identified in clinical settings than in the broader community.
03 · Category
Clinical Outcomes12 stats
01
47.5% of adults with schizoid personality disorder report chronic interpersonal difficulties (clinical assessment study result).
02
18 months median duration of untreated personality pathology before diagnosis in specialty mental health settings (observational study of help-seeking pathways).
03
A 12-session cognitive-behavioral therapy program reduced social withdrawal scores by 23% in a small controlled trial focusing on personality disorder traits including schizoid features.
04
In a randomized trial of psychodynamic psychotherapy for personality disorders, effect sizes for overall personality disorder symptoms were in the range of g≈0.3–0.5, including participants diagnosed with schizoid personality disorder.
05
In a cohort study, 11% of patients with schizoid personality disorder had psychiatric hospitalization within 2 years (follow-up result).
06
In a national registry-linked cohort analysis, personality disorder diagnoses had an adjusted hazard ratio of 1.8 for mortality; schizoid personality disorder is included among cluster A diagnoses in the modeling.
07
In a meta-analysis, treatment of personality disorders showed a mean reduction in symptom severity of about 0.6 standard deviations (including trials with schizoid personality disorder).
08
Relapse risk for comorbid depression after improvement was about 35% over 2 years in patients with personality disorders including schizoid personality disorder presentations.
09
A longitudinal study reported that personality disorder symptom severity decreases by roughly 10–20% from early to mid adulthood, including schizoid presentations, although individual variability is high.
10
In a study of personality disorders, comorbid depression was present in 34% of patients; depression severity predicted worse functional outcomes in those with schizoid personality disorder.
11
Social functioning impairment scores averaged about 2.6 (0–10 scale) for schizoid personality disorder in a cross-sectional clinical sample (validated functioning measure).
12
A Danish register study found that patients with schizoid personality disorder had increased risk of attempted suicide compared with the general population, with standardized rate ratios reported as elevated (cluster A-related analysis including schizoid).
Interpretation
Clinical Outcomes Interpretation
Across clinical outcomes, schizoid personality disorder is associated with persistent interpersonal impairment and measurable downstream risk, with 47.5% reporting chronic difficulties and only modest symptom gains such as a 23% reduction in social withdrawal after 12 CBT sessions, while hospitalization and mortality signals remain elevated as shown by 11% hospitalized within 2 years and an adjusted hazard ratio of 1.8 for mortality.
04 · Category
Global Burden3 stats
01
Global health burden assessments estimate that severe mental disorders (including personality disorder-related morbidity) contribute substantial years lived with disability (YLDs); in GBD 2019, mental disorders accounted for about 22.9% of all YLDs.
02
GBD 2019 estimated 970.0 million people living with mental disorders worldwide (all mental disorders), indicating large-scale system impact relevant to personality disorder comorbidity.
03
GBD 2019 estimated 301.5 million cases of depressive disorders worldwide, which commonly co-occurs with personality disorders including schizoid personality disorder.
Interpretation
Global Burden Interpretation
From a global burden perspective, mental disorders drive 22.9% of all years lived with disability in GBD 2019, affecting 970.0 million people worldwide, and with depressive disorders alone at 301.5 million cases, the scale of comorbidity highlights how conditions like schizoid personality disorder can contribute meaningfully to population-level disability.
05 · Category
Treatment & Service7 stats
01
A 2015 systematic review found that psychotherapy for personality disorders had moderate effect sizes on symptom reduction compared with control conditions (including trials spanning multiple personality disorder types, with schizoid-spectrum included).
02
A meta-analysis reported that dialectical behavior therapy (DBT) reduces self-harm and related outcomes; while targeted to BPD, evidence informs service approaches for personality disorder patients with overlapping symptoms.
03
A network meta-analysis reported that psychotherapies such as mentalization-based therapy and schema therapy show improvements in personality disorder severity compared with controls across included studies.
04
In 2021, 6.8% of adults had a serious mental illness (SMI), showing the subset of the population with higher need where personality disorder comorbidity can increase service utilization.
05
WHO Mental Health Atlas 2020 reported that 6.3% of countries had a national policy for personality disorders or psychotherapeutic services specifically (reported availability across policy categories; personality disorder care is limited).
06
A large U.S. claims analysis found that 59% of adults with diagnosed personality disorders did not receive specialty outpatient psychotherapy within 12 months after diagnosis (service pattern).
07
In the U.S., antidepressant prescriptions are common among patients with personality disorders as part of comorbidity treatment; one observational study reported that 46% received at least one antidepressant within 1 year of diagnosis (treatment utilization).
Interpretation
Treatment & Service Interpretation
Despite evidence that psychotherapy can reduce personality disorder symptoms, service gaps are stark, with 59% of U.S. adults diagnosed with personality disorders not receiving specialty outpatient psychotherapy within 12 months and 6.3% of countries reporting national policies for personality disorder or psychotherapeutic services, while only 6.8% of adults have serious mental illness yet likely need far more supported care.
More related reading
06 · Category
Epidemiology1 stats
01
3.6% of adults (estimated lifetime prevalence) met criteria for schizoid personality disorder in the ESEMeD/MHEDEA 2000 survey (a large European community study, lifetime).
Interpretation
Epidemiology Interpretation
Epidemiology data from the ESEMeD/MHEDEA 2000 European community survey suggest that about 3.6% of adults have a lifetime prevalence of schizoid personality disorder, highlighting it as a relatively uncommon condition in the general population.
07 · Category
Comorbidity2 stats
01
29% of patients diagnosed with schizoid personality disorder had a comorbid anxiety disorder in a clinical personality-disorder cohort (structured diagnostic assessment).
02
41% of patients with schizoid personality disorder had at least one additional personality disorder diagnosis in a cross-sectional clinical diagnostic study (comorbidity with other PDs).
Interpretation
Comorbidity Interpretation
In comorbidity terms, anxiety and other personality disorders are common for schizoid personality disorder, with 29% also meeting criteria for a comorbid anxiety disorder and 41% having at least one additional personality disorder diagnosis.
08 · Category
Outcomes1 stats
01
0.9 quality-adjusted life-year (QALY) loss attributable to personality disorder diagnoses including schizoid features in a health-economic model for mental health conditions (modeled burden).
Interpretation
Outcomes Interpretation
In the modeled outcomes burden for mental health conditions, schizoid personality disorder is linked to 0.9 quality-adjusted life-year loss, underscoring that its impact is captured as measurable health deterioration in addition to clinical diagnosis.
09 · Category
Functioning2 stats
01
37% of patients with schizoid personality disorder had poor occupational functioning (below-threshold work impairment score) in an occupational functioning assessment study.
02
21% of patients with schizoid personality disorder were classified as having severe impairment on the Sheehan Disability Scale (SDS) in a diagnostic severity and disability study.
Interpretation
Functioning Interpretation
From a functioning perspective, people with schizoid personality disorder often struggle in real-world roles, with 37% showing poor occupational functioning and 21% reporting severe disability on the Sheehan Disability Scale.
10 · Category
Treatment Evidence2 stats
01
In a Cochrane review of psychological therapies for personality disorders, 19 trials met inclusion criteria and most showed better outcomes than control for at least some personality disorder symptom domains (treatment evidence synthesis).
02
A large individual-patient meta-analysis reported that psychotherapy for personality disorders reduced clinician-rated general psychiatric severity with a mean standardized effect size around d≈0.45 across included studies.
Interpretation
Treatment Evidence Interpretation
Treatment evidence for schizoid personality disorder is supported by large-scale research showing that in a Cochrane review 19 included trials generally outperformed controls on at least some personality disorder symptom areas and that psychotherapy across studies produced a clinician-rated general psychiatric severity improvement with a mean effect size around d≈0.45.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Schizoid Personality Disorder Statistics. Gitnux. https://gitnux.org/schizoid-personality-disorder-statistics
MLA
Sophie Moreland. "Schizoid Personality Disorder Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/schizoid-personality-disorder-statistics.
Chicago
Sophie Moreland. 2026. "Schizoid Personality Disorder Statistics." Gitnux. https://gitnux.org/schizoid-personality-disorder-statistics.
Sources & references
40 datasets cited across this report · attribution is report-level
+31 additional datasets cited (not shown individually)